-
Product Insights
NewCharcot-Marie-Tooth Disease Type I A – Drugs In Development, 2024
Empower your strategies with our Charcot-Marie-Tooth Disease Type I A – Drugs In Development, 2024 report and make more profitable business decisions. Charcot–Marie–Tooth disease type 1A (CMT1A), the most frequent form of CMT, is caused by a 1.5 Mb duplication on the short arm of chromosome 17. CMT1 is characterized by muscle weakness and atrophy, which can lead to repeated ankle sprains, and changes in sensation (paresthesia), which can cause clumsiness. Symptoms of this form of CMT usually start in childhood...